what bmi for glp-1 Pediatric obesity management algorithm. BMI, body mass index; GLP1, GLP-1 receptor agonist prescriptions for

Fact : GLP-1 weight-loss drugs are typically prescribed to people with a BMI of 30 or higher

In clinical trials, participants taking the highest dose of Foundayo lost an average of 1517% of their body weight over 36 to 72 weeks, compared to roughly 2% in the placebo group

Rapid weight loss after 50 takes muscle with it, not just fat, at an age when muscle and bone are already harder to keep than they were at 35

The FDA has specifically flagged risks including dosing errors, variable concentrations, improper storage during shipping, quality control differences, limited adverse-event reporting, and products falsely marketed for research or non-human-use purposes

With proper support and dosing adjustments, these effects usually resolve